Akers Logo Top Akers Biosciences  
Akers Logo Bottom
 
 
 
""


NEWS

26 JUN 2008 ABI Signs New Distribution Agreement with Trinity Biotech 

ABI has appointed Trinity Biotech plc as another partner for the distribution of the Company's PIFA® Heparin/Platelet Factor-4 Rapid Assay (HPF4) in the USA and German markets.  Trinity Biotech is a specialist in the marketing and distribution of clinical diagnostic products.

7 APR 2008  ABI Announces 2007 Financial Results

For the year ended 31 December, 2007, revenues totaled $5.5 million, the highest in the Company’s history. Other highlights include the first positive EBITDA of $1.4 million, which represents ABI’s maiden positive operating cash flow.

3 April 2008 Thomas A. Nicolette named Chief Executive Officer

Having successfully initiated ABI’s transition from R&D-based entity to a Sales and Marketing organization over the past twelve months, Thomas A. Nicolette has become CEO of the Company, effective immediately. Dr. Raymond F. Akers, Jr. will now hold the position of Executive Vice Chairman of the Board, continuing to lead the development of new products. Robert J. Paratore has been promoted to Chief Financial Officer.

 

For additional information, please call 1.800.451.TEST or +1 856 848 2116.

   

© 2008 Akers Biosciences, Inc. All Rights Reserved.
Technical Services